Leap Therapeutics Financial Overview
Leap Therapeutics's market cap is currently ―. The company's EPS TTM is $-0.08; its P/E ratio is ―; Leap Therapeutics is scheduled to report earnings on November 12, 2025, and the estimated EPS forecast is $―. See an overview of income statement, balance sheet, and cash flow financials.
